Zolsketil pegylated liposomal
Analogs of Zolsketil pegylated liposomal
Find cheaper analogs and generic equivalents for Zolsketil pegylated liposomal.
Active Ingredient: doxorubicin hydrochloride, liposomal
Product Overview
About Zolsketil pegylated liposomal
Zolsketil pegylated liposomal is a cytotoxic medicine that belongs to the group ‘anthracyclines’.
What it is used for
There is no information available on what Zolsketil pegylated liposomal is used for.
How it is used
Zolsketil pegylated liposomal can only be obtained with a prescription. It should only be given under the supervision of a cancer doctor who is specialised in the use of cytotoxic (cell-killing) medicines. It cannot be interchanged with other medicines that contain doxorubicin. Zolsketil pegylated liposomal is given by infusion (drip) into a vein. The dose depends on the condition it is used for and is calculated on the basis of the patient’s weight and height. The doctor may stop treatment or reduce the dose if certain side effects occur or if the patient has liver problems.
How it works
Doxorubicin, the active substance in Zolsketil pegylated liposomal, interferes with the DNA in cancer cells, preventing them from making more copies of DNA. This means that cancer cells cannot divide and eventually die. Zolsketil pegylated liposomal builds up in areas in the body where the blood vessels have an abnormal shape, such as within tumours, where its action is concentrated. Doxorubicin has been available since the 1960s. In Zolsketil pegylated liposomal, it is enclosed in ‘pegylated liposomes’ (tiny fat particles coated with a substance called polyethylene glycol). This slows down removal of the medicine, allowing it to circulate in the blood for longer. It also reduces its effects on healthy tissues and cells, so it is less likely to cause specific side effects.
Active substance: Doxorubicin
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
